Chase William J insider trades
Chase William J has filed 18 Form 4s with the SEC that we hold, for GRAIL, Inc. (GRAL) (Director) and Intellia Therapeutics, Inc. (NTLA) (Director). Across all of them we count 1 purchase worth $1.0M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 100,000 shares of Intellia Therapeutics, Inc. worth $1.0M, dated 2025-08-20. The first filing on our record is dated 2023-04-18 and the latest 2026-07-16.
GRAIL, Inc. (GRAL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Intellia Therapeutics, Inc. (NTLA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-08-20 | P, purchase reported on Form 4 | 100,000 | $1.0M | 2025-08-22 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1563572) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms